Novartis has agreed to pay $2.1 billion cash to acquire Endocyte, expanding an ongoing effort by the Swiss firm to develop targeted radiation treatments for cancer. Under the agreement, Novartis (NYSE: [[ticker:NVS]]) will pay shareholders of West Lafayette, IN-based Endocyte (NASDAQ: [[ticker:ECYT]]) $24 per share, which is a 54 percent premium to the closing price … Continue reading “Novartis Buys Endocyte for $2.1B, Making a Second Bet on Radiotherapy”
Category: Indiana
After $950K Investment, Codelicious Grows Collaborative Teaching Model
Codelicious, the Indianapolis-based educational tech startup, is on a mission to create access and remove barriers to teaching and learning computer science, says CEO Christine McDonnell. Over the summer, the organization raised nearly $1 million from Collina Ventures, GRE Capital, Elevate Ventures and others to advance its software platform that enables instructors to build their … Continue reading “After $950K Investment, Codelicious Grows Collaborative Teaching Model”
Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals
[Updated 10/17/18, 2:52 p.m. See below.] Express Scripts has just exerted its influence over the emerging market battle between drug makers trying to sell a new class of migraine-preventing medicines. The pharmacy benefits manager (PBM) is excluding a new drug from Teva Pharmaceutical from coverage while favoring two rival treatments instead, according to a report … Continue reading “Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals”
Startups, Eh? Latest Gener8tor Class Includes 2 Canadian Companies
Gener8tor went north of the border to find some of the participants in its latest Wisconsin startup accelerator program. The organization, which trains entrepreneurs and invests in some of the companies they run, appears to have picked two startups headquartered in Canada for Gener8tor’s current accelerator session in Milwaukee. The latest group of participants haven’t … Continue reading “Startups, Eh? Latest Gener8tor Class Includes 2 Canadian Companies”
SoftBank’s Arm to Include Cybereason Security Services in IoT Hub
Security-tech company Cybereason is announcing another boon flowing from close ties with its biggest investor, Japanese telecom and tech giant SoftBank. Boston-based Cybereason has formed a partnership with Arm, the dominant developer of computer chip architecture, which was acquired by SoftBank in 2016. Cybereason’s security services will be incorporated into the Arm Pelion IoT platform, a … Continue reading “SoftBank’s Arm to Include Cybereason Security Services in IoT Hub”
Citing Regulatory Uncertainty, Origin Code Academy to Close
Origin Code Academy, one of San Diego’s few coding schools—for-profit companies that offer short-term vocational training in computer programming—said this month it will shutter on Nov. 16 after about three years in business. The company opened in late 2015, offering a 12-week course for $13,500 and promising graduates a software job within 90 days of … Continue reading “Citing Regulatory Uncertainty, Origin Code Academy to Close”
Paul Allen’s Contributions, Far Beyond Microsoft, Touched the Brain, AI & More
Technology and life sciences leaders say they’ll remember Paul Allen, the Microsoft co-founder, philanthropist, and investor who passed away Monday at age 65, as an “inspiration” whose work will impact the fields he worked in for years to come. Allen died from complications of non-Hodgkin’s lymphoma, according to a statement from Vulcan, the Seattle-based philanthropy … Continue reading “Paul Allen’s Contributions, Far Beyond Microsoft, Touched the Brain, AI & More”
Tulerie Helps Users Dress Like Models, Without Breaking the Bank
Tulerie makes its debut today, joining a growing roster of online clothing rental startups. The New York-based Tulerie focuses on high-end couture—items that retail for $1,000 to $10,000—that might be worn a time or two but mostly take up space in a woman’s closet. The company is building a two-sided marketplace, with owners of haute … Continue reading “Tulerie Helps Users Dress Like Models, Without Breaking the Bank”
After Net Neutrality: How to Prepare for the Internet’s New Reality
The federal net neutrality regulation, which had guaranteed equal access to the Internet for data from all sources, is officially repealed. There are no longer federal rules ensuring that all Internet traffic must be treated equally, and no FCC protections to stop Internet Service Providers (ISPs) from engaging in blocking, throttling, or paid prioritization of … Continue reading “After Net Neutrality: How to Prepare for the Internet’s New Reality”
Room Service by Robot and Other Ways Tech Is Changing the Hotel Stay
More days than not, Michael Colaneri’s home is a hotel room. So innovations like “geolocation” sensors that automatically unlock his room door and adjust the thermostat when he’s nearby make the constant change easier—sometimes. “My experience has been exceptionally inconsistent,” he says. “When it’s worked, it’s really great, cool, and so efficient to the point … Continue reading “Room Service by Robot and Other Ways Tech Is Changing the Hotel Stay”
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
Nearly four years after investors snapped up new shares of Juno Therapeutics in a $265 million IPO, cancer immunotherapy remains a hot ticket. Like Juno, Allogene Therapeutics just pulled in a massive IPO haul, nearly $300 million. And like Juno, Allogene is working with a live immune-cell treatment called CAR-T, but it is harvesting cells … Continue reading “Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More”
Facebook Bars 800 Fake Accounts and Pages For Using Tactics Like Russia’s
In another wave of account shutdowns, Facebook announced Thursday that it disabled more than 800 pages and accounts to prevent groups that disguised their identities from flooding its network with inauthentic content—some of it hyper-partisan political messages. Facebook (NASDAQ: [[ticker:FB]]) has been under pressure to cleanse its pages of fake news since the discovery that … Continue reading “Facebook Bars 800 Fake Accounts and Pages For Using Tactics Like Russia’s”
BIO Has Big Diversity Goals. Does It Have the Means to Reach Them?
Whether from embarrassing parties or sobering surveys, the biotech gender gap problem has made plenty of headlines the past couple years. The industry’s largest trade group, the Biotechnology Industry Organization (BIO), is trying to encourage its more than 1,000 member companies to do better. Last winter, BIO posted diversity goals for the industry to hit … Continue reading “BIO Has Big Diversity Goals. Does It Have the Means to Reach Them?”
Tim Berners-Lee Building Inrupt to Fix the Web—Will Users Come?
The World Wide Web is at a crossroads. For all the benefits it has brought society over the past three decades—faster and easier communication, instant knowledge access, a seemingly inexhaustible marketplace of goods and services—the Web has also morphed into an “engine of inequity and division,” according to its inventor, Tim Berners-Lee (pictured above). In … Continue reading “Tim Berners-Lee Building Inrupt to Fix the Web—Will Users Come?”
Planes, Drones & Automobiles: Techstars Grads Run the Mobility Gamut
On Tuesday afternoon, before a packed house at the Detroit Institute of Art’s film theatre, 11 startups just finishing a summer stint in the Techstars Mobility accelerator program took to the stage to talk more about what their companies were developing. Company founders pitched to a crowd of investors, entrepreneurs, automotive and tech executives, and … Continue reading “Planes, Drones & Automobiles: Techstars Grads Run the Mobility Gamut”
Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M
San Francisco-based Anaplan, one of five companies planning to close initial public offerings this week, raised the expected price range for its shares in an SEC filing Wednesday, signaling an IPO that could be richer than it had anticipated. Enterprise planning software company Anaplan, which is privately valued at more than $1.4 billion, had originally … Continue reading “Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M”
BioCrossroads Unveils New $9M Seed Fund for Biotech, Agbio Startups
Biotech startups in the Hoosier State now have a new source of funding for innovations at the early stage of development. BioCrossroads on Wednesday announced a $9 million seed fund. It’s the third fund for the public-private partnership, which formed to support the growth of the life sciences industry in Indiana. The latest fund will … Continue reading “BioCrossroads Unveils New $9M Seed Fund for Biotech, Agbio Startups”
U.S. Venture Capital Deals on Pace to Exceed $100B in 2018
Once considered a passing phase, the concentration of capital into fewer, larger venture capital deals appears to be the new normal. Fueled by so-called mega-funds, investment in U.S.-based venture-backed companies as of the end of the third quarter hit a decade high, and is on pace to pass the $100 billion mark by year’s end. … Continue reading “U.S. Venture Capital Deals on Pace to Exceed $100B in 2018”
With a $10.2M Boost, YourMechanic Aims at Mobility Fleet Market
Every month, there’s news of another partnership among carmakers like GM and tech companies such as Uber, as they vie for dominant roles in a transportation future where individual car ownership may largely give way to rides-on-demand from fleets of autonomous and tech-enabled vehicles. But whether Uber, Toyota, GM, Honda, or Google end up at … Continue reading “With a $10.2M Boost, YourMechanic Aims at Mobility Fleet Market”
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More
Cancer immunotherapy is all the rage these days. The idea of harnessing the immune system to treat cancer has sparked billions of dollars in research, led to a vast matrix of clinical trials, and started to change the way how several cancers are treated. The reason: When it works, cancer immunotherapy can lead to longer-lasting … Continue reading “Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More”
OneCause Snags $4M Investment, Plans to Expand Fundraising Platform
OneCause, an Indianapolis-based fundraising platform formerly known as BidPal, has experienced a few changes over the past year: It has a new name, acquired Great Feats in April, and raised $4 million in venture funding last month. “As we grew, we wanted to send a message to our clients and team by putting ‘cause’ first [in … Continue reading “OneCause Snags $4M Investment, Plans to Expand Fundraising Platform”
Cloudera, Hortonworks Plan to Merge as $5.2B Cloud Data Platform
Cloudera and Hortonworks, two large, publicly traded companies that compete to offer Web-based data storage and analytics, announced plans today to merge into a combined entity they value at $5.2 billion. Share prices for the two Silicon Valley companies spiked in after-hours trading following the announcement Wednesday that both their boards approved the all-stock deal. Palo … Continue reading “Cloudera, Hortonworks Plan to Merge as $5.2B Cloud Data Platform”
Girls In Tech Showcases Women Founders In SF Pitch Competition
Kristina Tsvetanova says she found the motivation for her startup Blitab in 2014, when a blind colleague’s struggle to communicate via the Internet made her conscious of the barriers facing visually impaired people in a digital world. Her search for solutions spurred her to move from her native Bulgaria to find greater resources in Vienna, … Continue reading “Girls In Tech Showcases Women Founders In SF Pitch Competition”
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
[Updated, 9/28/18, 12:54 p.m. See below.] An Eli Lilly drug developed to prevent migraine headache pain before it starts has won FDA approval. The FDA decision announced late Thursday marks the third drug in this new class of medicines to receive the regulatory nod this year. Two weeks ago, the FDA approved a migraine drug … Continue reading “Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines”
Findera Tries a Pivot Amid a Whirlwind Over Data Privacy Rules
Early last year, the San Francisco startup Yozio decided it would have to scuttle its core mission, despite having attracted marquee customers including Pinterest and Airbnb within only a few years. The problem was, there turned out to be too few such websites with the size and sophistication to use Yozio’s app-optimization tools to advantage, … Continue reading “Findera Tries a Pivot Amid a Whirlwind Over Data Privacy Rules”
XRC Labs Showcases Retail Tech Innovations in VR, AI, Big Data
XRC Labs, an accelerator program focused on e-commerce and retail startups, held a demo day for its latest class Thursday, featuring innovations in artificial intelligence, virtual reality, and other technologies. The group of 10 startups is the sixth class for New York-based XRC, which was founded three years ago to promote innovation in the disruptive … Continue reading “XRC Labs Showcases Retail Tech Innovations in VR, AI, Big Data”
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More
Six years ago, a biotech called Amarin won FDA approval of a prescription fish-oil pill, Vascepa, because it could lower triglycerides, a type of fat in the blood. But Amarin didn’t have the evidence that lowering triglycerides with fish oil would really help people. Sales lagged. Amarin’s shares sank. While other groups tested other fish … Continue reading “Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More”
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
The window for life science IPOs is still open, and five biotechs and one medical device company chose the last week of the third quarter to make their stock market debuts. Gritstone Oncology (NASDAQ: [[ticker:GRTS]]) closed out the week by raising $100 million in an upsized IPO. On Thursday night, Emeryville, CA-based Gritstone priced its … Continue reading “Six Life Science Firms Close Q3 with an IPO, More Are on the Way”
Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk
Eli Lilly has a blockbuster diabetes drug, dulaglutide (Trulicity), which helps the body make more insulin. But that drug, and others in the same class, are injectables. A number of companies are trying to offer patients a pill alternative. Lilly (NYSE: [[ticker:LLY]]) now has a new pill drug candidate in its pipeline. The Indianapolis pharmaceutical … Continue reading “Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk”
Where Can Influential Companies Go to Meet Exceptional Black VCs?
Culture Shifting Weekend—a November 1-3 invitation-only summit, presented by Culture Shift Labs (CSL)—will offer a rare opportunity for leading companies and investors to meet, vet, and fund the fast-growing ecosystem of Black venture capitalists and VC firms. Hosted at Infor in New York City, Culture Shift Lab’s annual three-day event will enable institutional investors, social … Continue reading “Where Can Influential Companies Go to Meet Exceptional Black VCs?”
Author Hits Detroit to Discuss Dangers of Automating Public Assistance
There are few life events more stressful than suddenly losing a job. One of the safety net measures in place for displaced workers is unemployment insurance: reoccurring, state-administered benefit checks that eligible workers receive for a few months while trying to get back on their feet. That’s how the system is supposed to work, anyway. … Continue reading “Author Hits Detroit to Discuss Dangers of Automating Public Assistance”
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
There was more news this morning in the advancement of precision cancer drugs, which target a tumor’s genetic signature. Roche plans to file for approval of entrectinib, a drug the Swiss firm acquired when it bought San Diego, CA-based Ignyta for $1.7 billion last year. Roche’s Genentech unit provided updated data pooled from three early … Continue reading “Another Precision Step for Roche as Ignyta Drug Heads to Regulators”
How Groups Are Closing the Security Skills Gap, Boosting Diversity
Today, there is a massive shortage of cybersecurity talent across the globe. According to a 2015 study from Frost & Sullivan and the (ISC)² Foundation, there could be more than 1.5 million unfilled cybersecurity positions globally by 2020. As cybersecurity attacks and data breaches, unfortunately, become a matter of not if but when, security talent … Continue reading “How Groups Are Closing the Security Skills Gap, Boosting Diversity”
Adobe-Marketo Deal Could Spur Marketing Tech Tie-Ups, New Strategies
Marketo almost didn’t get off the ground. It was 2006, and Jon Miller and his Marketo co-founders were struggling to raise money from investors for their marketing technology startup. Their pitch was to use software to help businesses automate much of the process of tracking and managing the online sales leads they were getting from … Continue reading “Adobe-Marketo Deal Could Spur Marketing Tech Tie-Ups, New Strategies”
Sigstr Snags $4M Funding Round as Marketing Tech Sector Gets Hotter
Sigstr, the Indianapolis-based marketing tech startup, announced this week that it has raised $4 million in new venture funding. The round was led by Edison Partners, with participation from past investors, including Hyde Park Venture Partners, HubSpot Ventures, High Alpha Capital, Battery Ventures, and 4G Ventures. Bryan Wade, Sigstr’s CEO, says the company plans to … Continue reading “Sigstr Snags $4M Funding Round as Marketing Tech Sector Gets Hotter”
In Adobe’s $4.75B Acquisition of Marketo, a Signal for Marketing Tech
Tech giant Adobe announced Thursday it is buying marketing-software firm Marketo for $4.75 billion. The move may have a ripple effect on the realm of enterprise sales and marketing. Marketo, based in San Mateo, CA, was founded in 2006 and built its business on marketing automation—using software to track and manage potential customers’ interactions with … Continue reading “In Adobe’s $4.75B Acquisition of Marketo, a Signal for Marketing Tech”
Bio Roundup: Little Rhody, More for Migraine, Opioid Bills & More
The U.S. Senate had a rare moment of agreement, overwhelmingly passing a package of opioid-related bills. Up the East Coast, life-science players in Rhode Island are working to bring different local factions together and boost the state’s economy. Across the country, a similar effort is underway in Los Angeles. There were also plenty of headlines … Continue reading “Bio Roundup: Little Rhody, More for Migraine, Opioid Bills & More”
Convoy Reloads With $185M For Its Freight Shipment Marketplace
Convoy, an online marketplace that connects shippers with freight truck fleets and independent drivers, announced today it raised $185 million in a Series C fundraising round led by CapitalG, the growth equity investment fund of Alphabet, Google’s parent company. With its new funding, Seattle-based Convoy plans to continue expanding its network of customers and truckers … Continue reading “Convoy Reloads With $185M For Its Freight Shipment Marketplace”
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly
Elanco is now a standalone company after raising $1.5 billion in its stock market debut. Greenfield, IN-based Elanco (NYSE: [[ticker:ELAN]]) sold 62.9 million shares at $24 apiece, which topped the $20 to $23 range it had initially targeted. Investors showed their appetite for the animal health company, driving its stock price up more than 39 … Continue reading “Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly”
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
[Updated 9/19/18, 3:40 p.m. See below.] Tiny Rhode Island and its capital city Providence have always punched above their weight, for better or for worse. Better: Little Rhody’s founder Roger Williams, fleeing religious persecution in 17th-century puritanical Massachusetts, was one of America’s first abolitionists and created the concept of the separation of church and state. … Continue reading “In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect”
UiPath Snags $225M To Expand Robotic Workforce for Businesses
Top venture capital firms continue to pour money into software robotics companies that promise to automate monotonous business operations, like processing mortgage applications, that are often performed by humans. New York-based UiPath is the latest such company to score a haul, announcing Tuesday it raised $225 million in a Series C funding round co-led by … Continue reading “UiPath Snags $225M To Expand Robotic Workforce for Businesses”
Emplify Bags $7.5M to Give Employers Better Staff Engagement Data
Emplify, the Fishers, IN-based startup focused on software to improve employee engagement, today announced that it has raised a $7.5 million Series A funding round. Since it was spun out of Bluebridge in 2016, co-founder and CEO Santiago Jaramillo says Emplify has experienced swift growth—customers include Harley-Davidson and Terminus—and now has 65 employees. “We’re bigger … Continue reading “Emplify Bags $7.5M to Give Employers Better Staff Engagement Data”
Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen’s
A Teva Pharmaceutical migraine-prevention drug has won FDA approval, the second therapy in this new drug class to receive the regulatory nod this year. The Friday approval for the Teva (NYSE: [[ticker:TEVA]]) drug fremanezumab (Ajovy) came a little earlier than expected; the target date for the FDA decision was Sept. 16. The drug is part … Continue reading “Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen’s”
The Rise of Robocalls and Cell Scams—and How to Stop Them
[Updated 9:15 a.m., see below.] Jen King was in a hurry to get out the door of her Bay Area home on a recent morning, and she missed a call to her cell phone because of it. The phone number that called her, she later discovered, was startling. “It was my home phone calling me, … Continue reading “The Rise of Robocalls and Cell Scams—and How to Stop Them”
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More
The long-running patent feud over CRISPR-Cas9 gene editing appears to be over, just as U.S. biotech companies gear up for the first human tests of the landmark technology. This week, a federal appeals court upheld a previous ruling handing a CRISPR-Cas9 patent to the Broad Institute of MIT and Harvard. The decision by the three-judge … Continue reading “Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More”
With Cornershop, Walmart Expands On-Demand Delivery to Latin America
Walmart is taking the e-commerce delivery business south of the border. The Bentonville, AR, retailer announced Thursday it has acquired Cornershop, an on-demand online service that delivers products from supermarkets, pharmacies, and specialty shops in Mexico and Chile, for $225 million. “We are focused on making life easier for customers and associates by building strong … Continue reading “With Cornershop, Walmart Expands On-Demand Delivery to Latin America”
Living on the Edge: Amazon, AT&T, Packet Pursue “Cloudlet” Computing
The word “cloud”—as in cloud computing, and cloud storage—has served as a handy shorthand term, but it has always been inherently vague and a little misleading. When businesses and consumers use a cloud service provider like Amazon Web Services or Apple’s iCloud, their data, photos, and music don’t get processed in the misty skies above … Continue reading “Living on the Edge: Amazon, AT&T, Packet Pursue “Cloudlet” Computing”
South Bend Code School Adds Revenue Stream with Code Works Dev Shop
When South Bend Code School launched in 2015, its founders were looking for a way to teach kids career skills that might enable them to find a job without a college degree. As that effort grew and gained popularity, people in the community began reaching out to SBCS seeking software development work. “As we were … Continue reading “South Bend Code School Adds Revenue Stream with Code Works Dev Shop”
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away
If you’re still recovering from a Labor Day hangover or busy searching for the identity of the anonymous writer of the anti-Trump op-ed for the New York Times, you may have missed a few biomedical firsts. This week brought the first sliver of human data from an in-body gene editing procedure, and the results were … Continue reading “Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away”
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More
Before you head out for the final summer getaway, catch up on the week’s headlines. Pfizer upped the ante in the field of transthyretin amyloidosis (ATTR) treatment, where competition to treat the rare disease has grown increasingly complex. We’ll start with what was—and wasn’t—in Pfizer’s data release Monday, top up with more ATTR news, then … Continue reading “Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More”